|
|
|
|
Myeloproliferative Diseases
Amarillo Biosciences Appoint Gary Coy as CFO 14 Mar 2006
Market Wire (press release) ...of conditions, including Sjogren's syndrome, Behcet's disease, idiopathic pulmonary fibrosis, hepatitis B, myeloproliferative diseases and opportunistic ...
Researchers Closer to Understanding How One Mutation Causes Three ... Dec 19, 2005
Howard Hughes Medical Institute, Although more research is needed, “these studies advance our understanding of the basis of myeloproliferative diseases,� Gilliland said. ...
Discoveries Reveal Gene Mutation That Causes Blood Disorders Dec 11, 2005
PR Newswire (press release), ASH) have discovered a single point mutation in the JAK2 gene that is expressed in a high percentage of patients with one of three myeloproliferative diseases. ...
Source: Quest Diagnostics Incorporated Dec 9, 2005
Yahoo! News (press release) The JAK2 mutation is the most common genomic abnormality in myeloproliferative diseases involving blood cells derived from bone marrow (polycythemia vera ...
Support groups Nov 27, 2005
Huntsville Times, Group, for families and friends of patients with leukemia, Hodgkin's disease, lymphoma or multiple myeloma and other myeloproliferative diseases, The Center ...
Found! First gene associated with myeloproliferative diseases Aug 26, 2005
Myelodysplastic / myeloproliferative diseases (MDS/MPD) are blood stem cell disorders characterized by ineffective formation and development of blood cells in ... Innovations-Report,
Found! First gene associated with myeloproliferative diseases -- Aug 26, 2005
Myelodysplastic / myeloproliferative diseases (MDS/MPD) are blood stem cell disorders characterized by ineffective formation and development of blood cells in ... / Innovations-Report,
Found! First gene associated with myeloproliferative diseases Aug 26, 2005
Myelodysplastic / myeloproliferative diseases (MDS/MPD) are blood stem cell disorders characterized by ineffective formation and development of blood cells in ... Innovations-Report,
Trio Of Leukemias Share A Single Mutation May 31, 2005
The researchers concentrated on the enzymes because activated tyrosine kinases had been shown to cause other similar myeloproliferative diseases such as CML ... Science Daily (press release)
Polycythemia Vera and Essential Thrombocythemia Aug 25, 2004
...and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Director, Center for the Chronic Myeloproliferative Diseases, Johns Hopkins ... Medscape (subscription)
Polycythemia Vera and Essential Thrombocythemia -- Aug 25, 2004
...and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Director, Center for the Chronic Myeloproliferative Diseases, Johns Hopkins ... / Medscape (subscription)
[an error occurred while processing this directive]
The myeloproliferative diseases are a group of diseases of the bone marrow where excess cells are produced. The delineation from leukemia is artificial, although the myeloproliferative diseases on the whole have a much better prognosis than the leukemias. The concept was first proposed in 1951 by the eminent hematologist William Dameshek.
The myeloproliferative diseases are:- Chronic myelogenous leukemia (CML)
- Polycythemia vera (PCV)
- Essential thrombocytosis (ET)
- Myelofibrosis (increased connective tissue with decreased room for production of normal blood cells).
All MPDs arise from precursors of the "myeloid" lineage in the bone marrow. The lymphoid lineage may produce similar diseases, the lymphoproliferative disorders (acute lymphoblastic leukemia, lymphomas, chronic lymphocytic leukemia and multiple myeloma).
|
|
|
